Adenovirus-based transient expression systems for peritoneal membrane research.
BACKGROUND
Peritoneal membrane research has provided important insights into the physiology and pathophysiology of this tissue that is of vital importance for peritoneal dialysis patients. Among the various tools and methodologies used to study the peritoneum, we have extensively used adenovirus-mediated gene transfer.


METHODS
A literature review was carried out. Information from reviewed papers was combined with the authors' experience and results.


RESULTS
We have used first-generation adenoviruses that are simple to construct and can infect a wide range of dividing and nondividing cell types. These vectors are restricted, however, in that they provide only a short duration of transgene expression and may elicit an inflammatory response. Modifications to this technology with helper-dependent adenovirus may circumvent these problems but with increased complexity of construction. Adenovirus-mediated gene transfer has been used to evaluate the effect of several cytokines and growth factors on peritoneal membrane physiology. We have used intraperitoneal delivery of transforming growth factor-beta to generate an experimental model system of resolving peritoneal fibrosis and epithelial mesenchymal transdifferentiation. We have studied the effects of the inflammatory cytokines interleukin-1beta and tumor necrosis factor alpha on the peritoneum, and have shown that antiangiogenic factors such as sFLT-1 and angiostatin can reduce the damaging effects of exposure to peritoneal dialysis solutions in an animal model.


CONCLUSIONS
The use of recombinant adenoviruses to genetically modify cells and tissues is now a common laboratory research tool. This technique has provided important advances in our understanding of the peritoneal membrane.
Hoff
Catherine M
CM
Scientific Affairs, Renal Division, Baxter Healthcare Corporation, McGaw Park, Illinois 60085, USA. Cathy_Hoff@baxter.edu
Margetts
Peter J
PJ
D000256:Adenoviridae; D000818:Animals; D016207:Cytokines / Q000096:biosynthesis*; D015314:Dialysis Solutions / Q000494:pharmacology; D005355:Fibrosis / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control; D018014:Gene Transfer Techniques; D005822:Genetic Vectors; D006801:Humans; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D010537:Peritoneum / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology
D016207:Cytokines; D015314:Dialysis Solutions